Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Nanoparticle Paclitaxel
DRUG
2 trials
Sponsors
Celgene Corporation
Conditions
Coronary Restenosis
Vascular Disease, Peripheral
Phase 1
Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis
Completed
NCT00124943
Celgene Corporation
Coronary Restenosis
Start: 2005-07-31
End: 2009-08-31
Updated: 2012-04-02
Phase 2
Prevention of Restenosis Following Revascularization
Terminated
NCT00518284
Celgene Corporation
Vascular Disease, Peripheral
Start: 2008-01-31
End: 2009-09-30
Updated: 2012-03-13